Evidence map›Paper›PMID 37993801›Full record

ArticleBMC medical imaging2023

Exploring the efficacy of multi-flavored feature extraction with radiomics and deep features for prostate cancer grading on mpMRI.

Hasan Khanfari, Saeed Mehranfar, Mohsen Cheki, Mahmoud Mohammadi Sadr, Samir Moniri, Sahel Heydarheydari, Seyed Masoud Rezaeijo

Abstract read
In one paragraph

Article in BMC medical imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Development of anQuantitative imaging in medicine and surgery · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hasan KhanfariDepartment of Mechanical Engineering, Petroleum University of Technology, Ahvaz, Iran.
Saeed MehranfarDepartment of Electrical Engineering, Amirkabir University of Technology, Tehran, Iran.
Mohsen ChekiDepartment of Medical Imaging and Radiation Sciences, Faculty of Paramedicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Mahmoud Mohammadi SadrDepartment of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Samir MoniriDepartment of Medical Imaging and Radiation Sciences, Faculty of Paramedicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Sahel HeydarheydariDepartment of Medical Imaging and Radiation Sciences, Faculty of Paramedicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Seyed Masoud RezaeijoDepartment of Medical Physics, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. rezaei-sm@ajums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe purpose of this study is to investigate the use of radiomics and deep features obtained from multiparametric magnetic resonance imaging (mpMRI) for grading prostate cancer. We propose a novel approach called multi-flavored feature extraction or tensor, which combines four mpMRI images using eight different fusion techniques to create 52 images or datasets for each patient. We evaluate the effectiveness of this approach in grading prostate cancer and compare it to traditional methods.

methodsWe used the PROSTATEx-2 dataset consisting of 111 patients' images from T2W-transverse, T2W-sagittal, DWI, and ADC images. We used eight fusion techniques to merge T2W, DWI, and ADC images, namely Laplacian Pyramid, Ratio of the low-pass pyramid, Discrete Wavelet Transform, Dual-Tree Complex Wavelet Transform, Curvelet Transform, Wavelet Fusion, Weighted Fusion, and Principal Component Analysis. Prostate cancer images were manually segmented, and radiomics features were extracted using the Pyradiomics library in Python. We also used an Autoencoder for deep feature extraction. We used five different feature sets to train the classifiers: all radiomics features, all deep features, radiomics features linked with PCA, deep features linked with PCA, and a combination of radiomics and deep features. We processed the data, including balancing, standardization, PCA, correlation, and Least Absolute Shrinkage and Selection Operator (LASSO) regression. Finally, we used nine classifiers to classify different Gleason grades.

resultsOur results show that the SVM classifier with deep features linked with PCA achieved the most promising results, with an AUC of 0.94 and a balanced accuracy of 0.79. Logistic regression performed best when using only the deep features, with an AUC of 0.93 and balanced accuracy of 0.76. Gaussian Naive Bayes had lower performance compared to other classifiers, while KNN achieved high performance using deep features linked with PCA. Random Forest performed well with the combination of deep features and radiomics features, achieving an AUC of 0.94 and balanced accuracy of 0.76. The Voting classifiers showed higher performance when using only the deep features, with Voting 2 achieving the highest performance, with an AUC of 0.95 and balanced accuracy of 0.78.

conclusionOur study concludes that the proposed multi-flavored feature extraction or tensor approach using radiomics and deep features can be an effective method for grading prostate cancer. Our findings suggest that deep features may be more effective than radiomics features alone in accurately classifying prostate cancer.

Indexed as

Multiparametric Magnetic Resonance ImagingProstatic NeoplasmsBayes TheoremHumansLogistic ModelsMagnetic Resonance ImagingMaleRetrospective StudiesDeep featuresGradingmpMRIProstate cancerRadiomics features

Identifiers

PMID37993801
PMCPMC10664625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.